Kezar Life Sciences (KZR) Misses Q3 EPS by 153c

Kezar Life Sciences (NASDAQ: KZR) reported Q3 EPS of ($1.53).

For earnings history and earnings-related data on Kezar Life Sciences (KZR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold